{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:45Z","timestamp":1793237685656,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007149","name":"Genopole","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101080690"],"award-info":[{"award-number":["101080690"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007352","name":"Staatssekretariat f\u00fcr Bildung, Forschung und Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020987","name":"Universit\u00e9 d'\u00c9vry Val-d'Essonne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020987","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004152","name":"Spine Education and Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["GeneHumdi-CA21113"],"award-info":[{"award-number":["GeneHumdi-CA21113"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["PEMGeT ANR-22-CE17-0028-02"],"award-info":[{"award-number":["PEMGeT ANR-22-CE17-0028-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-CE17-0016-0"],"award-info":[{"award-number":["ANR-20-CE17-0016-0"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["NEEDED ANR-24-CE18-3712-01"],"award-info":[{"award-number":["NEEDED ANR-24-CE18-3712-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["IRIS ANR--21-CE14-0063-03"],"award-info":[{"award-number":["IRIS ANR--21-CE14-0063-03"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymthe.2026.03.025","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:25:27Z","timestamp":1774373127000},"page":"3903-3923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["CRISPR-Cas9-mediated upregulation of utrophin ameliorates Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"34","author":[{"given":"Ma\u00eblle","family":"Ralu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Guiraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumitava","family":"Dastidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Sadaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fetta","family":"Mazed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"de Cian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mamchaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ronzitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Saverio","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1188-8856","authenticated-orcid":false,"given":"Mario","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.03.025_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2026.03.025_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The Pathogenesis and Therapy of Muscular Dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.03.025_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","article-title":"Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis","volume":"15","author":"Crisafulli","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2026.03.025_bib4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41431-022-01138-2","article-title":"Incidence of Duchenne muscular dystrophy in the modern era; an Australian study","volume":"30","author":"Kariyawasam","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.03.025_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/323646a0","article-title":"Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene","volume":"323","author":"Monaco","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.025_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2026.03.025_bib7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nrm2024","article-title":"Molecular mechanisms of muscular dystrophies: old and new players","volume":"7","author":"Davies","year":"2006","journal-title":"Nat. Rev. Mol. Cel Biol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13023-021-01862-w","article-title":"The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review","volume":"16","author":"Szabo","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2026.03.025_bib9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacbts.2021.11.004","article-title":"Cardiovascular Disease in Duchenne Muscular Dystrophy","volume":"7","author":"Schultz","year":"2022","journal-title":"JACC. Basic Transl. Sci."},{"key":"10.1016\/j.ymthe.2026.03.025_bib10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","article-title":"Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: A comparative study from the Pediatric Cardiomyopathy Registry","volume":"155","author":"Connuck","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ymthe.2026.03.025_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/mus.880100212","article-title":"Management of end stage respiratory failure in Duchenne muscular dystrophy","volume":"10","author":"Bach","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2026.03.025_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.rehab.2013.06.002","article-title":"Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011","volume":"56","author":"Kieny","year":"2013","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"10.1016\/j.ymthe.2026.03.025_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.23808","volume":"48","author":"Henricson","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2026.03.025_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.03.025_bib15","doi-asserted-by":"crossref","first-page":"e2146","DOI":"10.1212\/WNL.0000000000005680","article-title":"Eteplirsen treatment for Duchenne muscular dystrophy","volume":"90","author":"Charleston","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2026.03.025_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1358\/dot.2020.56.8.3159186","article-title":"Golodirsen for Duchenne muscular dystrophy","volume":"56","author":"Anwar","year":"2020","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.ymthe.2026.03.025_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JND-220811","article-title":"Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy","volume":"9","author":"Clemens","year":"2022","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymthe.2026.03.025_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1358\/dot.2021.57.12.3352740","article-title":"Casimersen for Duchenne muscular dystrophy","volume":"57","author":"Wilton-Clark","year":"2021","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.ymthe.2026.03.025_bib19","series-title":"FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy","year":"2024"},{"key":"10.1016\/j.ymthe.2026.03.025_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin Immunity in Duchenne\u2019s Muscular Dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.03.025_bib21","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2212912","article-title":"Dystrophin Immunity after Gene Therapy for Duchenne\u2019s Muscular Dystrophy","volume":"388","author":"B\u00f6nnemann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.03.025_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41598-024-84077-w","article-title":"Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy","volume":"15","author":"Potter","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.03.025_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1750-3639.1996.tb00781.x","article-title":"Utrophin: A Structural and Functional Comparison to Dystrophin","volume":"6","author":"Blake","year":"1996","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib24","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1073\/pnas.1323842111","article-title":"Microtubule binding distinguishes dystrophin from utrophin","volume":"111","author":"Belanto","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.025_bib25","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1073\/pnas.0812007106","article-title":"Dystrophin and utrophin have distinct effects on the structural dynamics of actin","volume":"106","author":"Prochniewicz","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.025_bib26","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1074\/jbc.M513121200","article-title":"Dystrophin and Utrophin Bind Actin through Distinct Modes of Contact","volume":"281","author":"Rybakova","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.03.025_bib27","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1242\/jcs.064808","article-title":"Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin","volume":"123","author":"Li","year":"2010","journal-title":"J. Cel Sci."},{"key":"10.1016\/j.ymthe.2026.03.025_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","article-title":"Dystrophin, its interactions with other proteins, and implications for muscular dystrophy","volume":"1772","author":"Ervasti","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2026.03.025_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF02388063","article-title":"Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle","volume":"25","author":"Clerk","year":"1993","journal-title":"Histochem. J."},{"key":"10.1016\/j.ymthe.2026.03.025_bib30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s42003-023-04666-9","article-title":"Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1\/2 inhibition","volume":"6","author":"Gleneadie","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0960-8966(91)90023-L","article-title":"Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle","volume":"1","author":"Khurana","year":"1991","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.03.025_bib32","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1083\/jcb.115.6.1695","volume":"115","author":"Nguyen","year":"1991","journal-title":"J. Cel Biol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1097-0029(20000401)49:1<90::AID-JEMT10>3.0.CO;2-L","article-title":"Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse","volume":"49","author":"Gramolini","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.ymthe.2026.03.025_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0960-8966(92)90004-P","article-title":"The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies","volume":"2","author":"Helliwell","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.03.025_bib35","doi-asserted-by":"crossref","first-page":"19106","DOI":"10.1074\/jbc.M109642200","article-title":"The Utrophin Gene Is Transcriptionally Up-regulated in Regenerating Muscle","volume":"277","author":"Galvagni","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.03.025_bib36","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/1873-3468.13099","article-title":"Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy","volume":"592","author":"Perkins","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2026.03.025_bib37","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/hmg\/ddl083","article-title":"Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy","volume":"15","author":"Kleopa","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.03.025_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150818","article-title":"Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies","volume":"11","author":"Janghra","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.03.025_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamaneurol.2013.4908","article-title":"Biochemical Characterization of Patients With In-Frame or Out-of-Frame DMD Deletions Pertinent to Exon 44 or 45 Skipping","volume":"71","author":"Anthony","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.medj.2023.02.005","article-title":"Unusually severe muscular dystrophy upon in-frame deletion of the dystrophin rod domain and lack of compensation by membrane-localized utrophin","volume":"4","author":"Gorokhova","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.ymthe.2026.03.025_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13395-017-0139-5","article-title":"Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle","volume":"7","author":"Kennedy","year":"2017","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2026.03.025_bib42","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/4033","article-title":"Expression of full-length utrophin prevents muscular dystrophy in mdx mice","volume":"4","author":"Tinsley","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.025_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2018.10.005","article-title":"Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2\/mdx Mice","volume":"11","author":"Kennedy","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.025_bib44","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/nm1197-1216","article-title":"Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice","volume":"3","author":"Deconinck","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.025_bib45","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41598-022-04892-x","article-title":"Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression","volume":"12","author":"Starikova","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.03.025_bib46","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.gt.3301941","article-title":"Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer","volume":"10","author":"Cerletti","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.03.025_bib47","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41591-019-0594-0","article-title":"Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models","volume":"25","author":"Song","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.025_bib48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0960-8966(01)00220-6","article-title":"Non-toxic ubiquitous over-expression of utrophin in the mdx mouse","volume":"11","author":"Fisher","year":"2001","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.03.025_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1152\/physiolgenomics.2000.3.3.133","article-title":"Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice","volume":"3","author":"Ebihara","year":"2000","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ymthe.2026.03.025_bib50","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1093\/hmg\/11.26.3333","article-title":"Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system","volume":"11","author":"Squire","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.03.025_bib51","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1091\/mbc.e06-12-1069","article-title":"Ets-2 Repressor Factor Silences Extrasynaptic Utrophin by N-Box\u2013mediated Repression in Skeletal Muscle","volume":"18","author":"Perkins","year":"2007","journal-title":"MBoC"},{"key":"10.1016\/j.ymthe.2026.03.025_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029376","article-title":"Translational Regulation of Utrophin by miRNAs","volume":"6","author":"Basu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2026.03.025_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76338-1","article-title":"PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD)","volume":"10","author":"Sengupta","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.03.025_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182676","article-title":"Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction","volume":"12","author":"Mishra","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.03.025_bib55","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A Programmable Dual-RNA\u2013Guided DNA Endonuclease in Adaptive Bacterial Immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.025_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/science.add8643","article-title":"CRISPR technology: A decade of genome editing is only the beginning","volume":"379","author":"Wang","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.025_bib57","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/ncomms7244","article-title":"Multiplex CRISPR\/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy","volume":"6","author":"Ousterout","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.025_bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.025_bib59","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.025_bib60","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.025_bib61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.03.025_bib62","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.omtn.2020.08.031","article-title":"Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells","volume":"22","author":"Sengupta","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.03.025_bib63","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","article-title":"In Vivo Target Gene Activation via CRISPR\/Cas9-Mediated Trans-epigenetic Modulation","volume":"171","author":"Liao","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.025_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102247","article-title":"Upregulation of utrophin improves the phenotype of Duchenne muscular dystrophy hiPSC-derived CMs","volume":"35","author":"Andrysiak","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.03.025_bib65","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41467-025-57831-5","article-title":"Activation of endogenous full-length utrophin by MyoAAV-UA as a therapeutic approach for Duchenne muscular dystrophy","volume":"16","author":"Wu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.025_bib66","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1083\/jcb.200101108","article-title":"Distinct regions in the 3\u2019 untranslated region are responsible for targeting and stabilizing utrophin transcripts in skeletal muscle cells","volume":"154","author":"Gramolini","year":"2001","journal-title":"J. Cel Biol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib67","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1093\/hmg\/ddt165","article-title":"Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics","volume":"22","author":"Amirouche","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.03.025_bib68","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/nar\/gkm1107","article-title":"Modulation of utrophin A mRNA stability in fast versus slow muscles via an AU-rich element and calcineurin signaling","volume":"36","author":"Chakkalakal","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.03.025_bib69","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1093\/nar\/gkt1350","article-title":"Converging pathways involving microRNA-206 and the RNA-binding protein KSRP control post-transcriptionally utrophin A expression in skeletal muscle","volume":"42","author":"Amirouche","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.03.025_bib70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13059-019-1625-3","article-title":"iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity","volume":"20","author":"Nobles","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib72","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1073\/pnas.96.6.3223","article-title":"Induction of utrophin gene expression by heregulin in skeletal muscle cells: Role of the N-box motif and GA binding protein","volume":"96","author":"Gramolini","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.025_bib73","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1093\/nar\/29.23.4843","article-title":"The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy","volume":"29","author":"Perkins","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.03.025_bib74","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","article-title":"Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering","volume":"23","author":"Maffioletti","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.03.025_bib75","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3389\/fphys.2018.01332","article-title":"Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic LMNA Mutations","volume":"9","author":"Steele-Stallard","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib76","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114526","article-title":"Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling","volume":"14","author":"Choi","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2026.03.025_bib77","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41596-022-00790-8","article-title":"3D human induced pluripotent stem cell\u2013derived bioengineered skeletal muscles for tissue, disease and therapy modeling","volume":"18","author":"Pinton","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.03.025_bib78","article-title":"Advanced human iPSC-based modelling of LMNA -related congenital muscular dystrophy enables development of targeted genetic therapies for muscle laminopathies","author":"Moore","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2026.03.025_bib79","doi-asserted-by":"crossref","DOI":"10.5493\/wjem.v15.i2.100548","article-title":"miRNA dysregulation in Duchenne muscular dystrophy comorbidities","volume":"15","author":"Sivakumar","year":"2025","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.03.025_bib80","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.0708115104","article-title":"Distinctive patterns of microRNA expression in primary muscular disorders","volume":"104","author":"Eisenberg","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.025_bib81","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.3390\/ijms20184638","article-title":"miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy","volume":"20","author":"Hrach","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.03.025_bib82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.omtm.2023.06.006","article-title":"CRISPR-Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein","volume":"30","author":"Egorova","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.025_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.03.025_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4910","article-title":"Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing","volume":"7","author":"Chemello","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2026.03.025_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97730-5","article-title":"Duchenne muscular dystrophy cell culture models created by CRISPR\/Cas9 gene editing and their application in drug screening","volume":"11","author":"Soblechero-Mart\u00edn","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.03.025_bib86","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature07242","article-title":"The impact of microRNAs on protein output","volume":"455","author":"Baek","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.025_bib87","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature07228","article-title":"Widespread changes in protein synthesis induced by microRNAs","volume":"455","author":"Selbach","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.025_bib88","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/d41587-021-00017-3","article-title":"CRISPR therapies march into clinic, but genotoxicity concerns linger","volume":"39","author":"Sheridan","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/crispr.2021.0120","article-title":"ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected","volume":"5","author":"Boutin","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.03.025_bib90","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/stcltm\/szac064","article-title":"CRISPRthripsis: The Risk of CRISPR\/Cas9-induced Chromothripsis in Gene Therapy","volume":"11","author":"Amendola","year":"2022","journal-title":"Stem Cell Transl. Med."},{"key":"10.1016\/j.ymthe.2026.03.025_bib91","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.03.025_bib92","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2026.03.025_bib93","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A T to G C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.025_bib94","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1038\/s41467-020-19230-w","article-title":"Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants","volume":"11","author":"Weinmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.025_bib95","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.025_bib96","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1038\/s41467-024-52002-4","article-title":"An engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species","volume":"15","author":"Vu Hong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.025_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103793","article-title":"Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems","volume":"28","author":"Aquino-Jarquin","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ymthe.2026.03.025_bib98","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1016\/j.molcel.2021.08.008","article-title":"Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cel"},{"key":"10.1016\/j.ymthe.2026.03.025_bib99","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.025_bib100","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41589-021-00868-6","article-title":"Programmed genome editing by a miniature CRISPR-Cas12f nuclease","volume":"17","author":"Wu","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib101","article-title":"Single-AAV CRISPR editing of skeletal muscle in non-human primates with NanoCas, an ultracompact nuclease","author":"Rauch","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2026.03.025_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-47800-9","article-title":"CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing","volume":"15","author":"Pedrazzoli","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.025_bib103","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1038\/s41467-021-26714-w","article-title":"Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice","volume":"12","author":"Kenjo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.025_bib105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41419-019-1307-9","article-title":"sPIF promotes myoblast differentiation and utrophin expression while inhibiting fibrosis in Duchenne muscular dystrophy via the H19\/miR-675\/let-7 and miR-21 pathways","volume":"10","author":"Morgoulis","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2026.03.025_bib106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019189","article-title":"Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse","volume":"6","author":"Tinsley","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.03.025_bib107","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jcsm.12531","article-title":"AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy","volume":"11","author":"Abou-Samra","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ymthe.2026.03.025_bib108","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s00018-017-2465-5","article-title":"Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin","volume":"74","author":"Lecompte","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2026.03.025_bib109","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/acfb3d","article-title":"Mimicking sarcolemmal damage in vitro: a contractile 3D model of skeletal muscle for drug testing in Duchenne muscular dystrophy","volume":"15","author":"Tejedera-Villafranca","year":"2023","journal-title":"Biofabrication"},{"key":"10.1016\/j.ymthe.2026.03.025_bib110","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/hmg\/ddz049","article-title":"The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy","volume":"28","author":"Guiraud","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.03.025_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nmd.2024.01.004","article-title":"Gene therapy delivered micro-dystrophins co-localize with transgenic utrophin in dystrophic skeletal muscle fibers","volume":"36","author":"Krishna","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2026.03.025_bib112","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.03.025_bib113","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13059-015-0846-3","article-title":"Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency","volume":"16","author":"Dang","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib114","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/crispr.2021.0113","article-title":"Inference of CRISPR Edits from Sanger Trace Data","volume":"5","author":"Conant","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.03.025_bib115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib116","article-title":"Advanced pipeline for CRISPR\/Cas9 off-targets detection in Guide-seq and related integration-based assays","author":"Corre","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2026.03.025_bib117","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1161\/CIRCRESAHA.117.312067","article-title":"MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo","volume":"122","author":"Sala","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2026.03.025_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202300845","article-title":"Real-time and Multichannel Measurement of Contractility of hiPSC-Derived 3D Skeletal Muscle using Fiber Optics-Based Sensing","volume":"8","author":"Iuliano","year":"2023","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.ymthe.2026.03.025_bib119","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1093\/hmg\/ddv154","article-title":"Second-generation compound for the modulation of utrophin in the therapy of DMD","volume":"24","author":"Guiraud","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.03.025_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:23:05Z","timestamp":1793236985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162600211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S152500162600211X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.025","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-Cas9-mediated upregulation of utrophin ameliorates Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}